1. Inicio
  2. Proyectos y Estudios
  3. A master protocol for a Phase 3, multicenter, open-label, long-term extension study to evaluate the longterm efficacy and safety of mirikizumab in children and adolescents with moderate-to-severe ulcerative colitis or Crohn’s disease,

A master protocol for a Phase 3, multicenter, open-label, long-term extension study to evaluate the longterm efficacy and safety of mirikizumab in children and adolescents with moderate-to-severe ulcerative colitis or Crohn’s disease,

Datos básicos

ENSAYO CLÍNICO I6T-MC-AMAZ HOSPITAL UNIVERSITARI I POLITÈCNIC LA FE Año de incio: 2024

Documentos

  • No hay documentos

Participantes

Grupos

Financiadores - Promotores

ELI LILLY AND COMPANY

Compartir